SCHEMBL4415532

SCHEMBL4415532

O=Cc1ccc(-c2ccc(Cl)cc2F)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.52
KIF11 P52732 1/20 0.44
FASN P49327 1/20 0.42
GRM2 Q14416 2/20 0.42
PTGS1 P23219 1/20 0.41
XDH P47989 1/20 0.39
DRD1 P21728 3/20 0.39
ALDH1A1 P00352 3/20 0.38
DRD2 P14416 1/20 0.38
DRD4 P21917 1/20 0.38
DRD5 P21918 1/20 0.38
DRD3 P35462 1/20 0.38
KMO O15229 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
KCNA3 P22001 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
AKR1C3 P42330 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14879527 0.89 HSD17B10 (0.52) HSD17B10KIF11FASNPTGS1XDH
SCHEMBL23638836 0.82 GRM2 (0.49) FASNGRM2KMOSMN1; SMN2KDM4E
SCHEMBL1725545 0.81 HSD17B10 (0.56) HSD17B10XDHALDH1A1SMN1; SMN2KDM4E
SCHEMBL31120808 0.81 PTGS1 (0.51) HSD17B10KIF11GRM2PTGS1DRD1
SCHEMBL416643 0.81 PTGS1 (0.51) HSD17B10KIF11GRM2PTGS1DRD1
SCHEMBL31067155 0.79 NPC1 (0.49) HSD17B10FASNGRM2SMN1; SMN2KDM4E
SCHEMBL20898100 0.79 NPC1 (0.49) HSD17B10FASNGRM2SMN1; SMN2KDM4E
SCHEMBL18304391 0.79 HSD17B10 (0.52) HSD17B10PTGS1XDHDRD1ALDH1A1
SCHEMBL3228270 0.79 HSD17B10 (0.52) HSD17B10GRM2XDHALDH1A1SMN1; SMN2
SCHEMBL17508159 0.79 CYP2A6 (0.52) KIF11GRM2PTGS1DRD1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3587406-B1 2-HYDROXY-1-{4-[(4-PHENYLPHENYL)CARBONYL]PIPERAZIN-1-YL}ETHAN-1-ONE DERIVATIVES AND RELATED COMPOUNDS AS FATTY ACID SYNTHASE (FASN) INHIBITORS FOR THE TREATMENT OF CANCER FORMA THERAPEUTICS INC (US) 2021-01-27 EP disclosed
WO-2014160649-A1 HYDROXAMIC ACID DERIVATIVES AS LPXC INHIBITORS FOR THE TREATMENT OF BACTERIAL INFECTIONS NOVARTIS AG (CH) 2014-10-02 WO disclosed
EP-1479671-B1 Pyrimidinone compounds SMITHKLINE BEECHAM PLC (GB) 2009-05-27 EP disclosed
US-7115616-B2 Pyrimidinone compounds SMITHKLINE BEECHAM PLC (GB) 2006-10-03 US disclosed
US-6953803-B1 1-[(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)]-2-(4-fluorobenzyl)thio-5-(1-methyl-4-pyrazolylmethyl)pyrimidin-4-one; enzyme inhibitors of lipoprotein associated phospholipase A2 (Lp-PLA2); atherosclerosis SMITHKLINE BEECHAM P.L.C. (GB) 2005-10-11 US disclosed